These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 15518764

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy and Safety of Basiliximab Versus Daclizumab in Kidney Transplantation: A Meta-Analysis.
    Sun ZJ, Du X, Su LL, Zhang XD, Wang W.
    Transplant Proc; 2015 Oct; 47(8):2439-45. PubMed ID: 26518947
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Late acute humoral rejection in low-risk renal transplant recipients induced with an interleukin-2 receptor antagonist and maintained with standard therapy: preliminary communication.
    Morales J, Contreras L, Zehnder C, Pinto V, Elberg M, Araneda S, Herzog C, Calabran L, Aguiló J, Ferrario M, Buckel E, Fierro JA.
    Transplant Proc; 2011 Oct; 43(6):2295-9. PubMed ID: 21839258
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S.
    Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501
    [Abstract] [Full Text] [Related]

  • 27. Anti-CD25 monoclonal antibody sequential immunosuppressive induction therapy in renal transplants with high risk of delayed graft function.
    González E, Gutiérrez E, Hernández Y, Roselló G, Gutiérrez MJ, Martínez EG, Manzanera MJ, García JA, Praga M, Morales JM, Andrés A.
    Transplant Proc; 2005 Nov 27; 37(9):3736-7. PubMed ID: 16386522
    [Abstract] [Full Text] [Related]

  • 28. Use of simulect can reduce the incidence of acute rejection and demonstrates with superior 3-year patient and graft survival rates in renal transplantation.
    Chu SH, Chiang YJ, Huang CC, Lee PH, Hu RH, Lai MK, Chueh SC, Tsai MK.
    Transplant Proc; 2004 Sep 27; 36(7):2108-9. PubMed ID: 15518763
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT, Baxter-Lowe LA, Garcia J, McEnhill M, Summers P, Hirose R, Lee M, Stock PG.
    Arch Surg; 2011 Jul 27; 146(7):824-9. PubMed ID: 21768429
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Basiliximab does not reduce the early rejection incidence in high-risk kidney recipients under tacrolimus-based immunosuppression.
    Cho WH, Lee HJ, Kim HT, Hwang EA, Han SY, Park SB, Kim HC.
    Transplant Proc; 2008 Sep 27; 40(7):2234-6. PubMed ID: 18790201
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody.
    Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM.
    N Engl J Med; 2000 Mar 02; 342(9):613-9. PubMed ID: 10699160
    [Abstract] [Full Text] [Related]

  • 36. Maintenance immunosuppression with intermittent intravenous IL-2 receptor antibody therapy in renal transplant recipients.
    Gabardi S, Catella J, Martin ST, Perrone R, Chandraker A, Magee CC, McDevitt-Potter LM.
    Ann Pharmacother; 2011 Sep 02; 45(9):e48. PubMed ID: 21811001
    [Abstract] [Full Text] [Related]

  • 37. Basiliximab induction in adult liver transplant recipients with 93% rejection-free patient and graft survival at 24 months.
    Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.
    Transplant Proc; 2006 Dec 02; 38(10):3633-5. PubMed ID: 17175352
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.